Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOLOLOL ROFLK LMAOMLOL LOL LOLMAOMALMAO Dunce. i stated pretty specifically that im not your guys research assistant and that the second email that I sent was a followup question related to the mice trials. You Dr, and NGR have consistently called me a liar, i just show you point blank that the previous post I made related to mice trials is a direct quote from their email. You continuing to say the email I posted about the mice trials is a fallacy, or are you just moving onto another topic because that doesn't suit your ignorant argument? Child. ROFL LMAO LOL god i remember when that was cool on AIM in the 90's.
Here you go you dunce. Peace
https://www.dropbox.com/s/qhmm4wocfc6s4f0/IMG_20161110_201136.png?dl=0
Frankly I don't care whether you believe it or not. The first email I received back from them has that exact language on the bottom of it and the second did not. You guys are truly hilarious. If the post doesn't fall within your preconceived thoughts you call bs when all I did was email the company, get a reply then email a follow-up question related to mice trials after it started to get discussed here and shared that information. I wont make the effort anymore and save you all the time of reading my opinions. For your own sake, why dont you spend all of 2 minutes and email and ask where they are at with mice trials and when you get the exact answer that I posted feel free to apologize or just keep it to yourself that I was being honest from the get go. Goodluck with your investments, you won't see another post from me here. Maybe if you post "news next week and end of dulution" it'll actually happen next week, you gotta be right eventually.
Dr. Will you please delete my post #23879. I did not read the small print and i'd rather stay within my bounds. thanks.
?"This communication (including any attachments) contains Premier Biomedical, Inc. privileged or confidential information intended for a specific individual and purpose, and is protected by law. It is not to be forwarded or disseminated to persons without a demonstrated "need-to-know", without authorization from Premier Biomedical, Inc. If you are not the intended recipient, you should delete this communication immediately and are hereby notified that any disclosure, copying, dissemination, or distribution of this communication, or the taking of any action based on it, is strictly prohibited. If you receive this communication in error, please notify us immediately by calling 352-535-0226. This email and it’s attachments are © 2016, Premier Biomedical, Inc. All rights reserved. Any unauthorized reproduction is illegal without written consent."
I know that i've been consistently criticized for not being overly positive here, but generally speaking, just about everything i've said hasn't been too far off. My issue with what is going on here is that the company is telling me that Redwood has nothing to do with this and I feel like they are just point blank lying, which throughout my life means I can't trust anything they say moving forward and that's ultimately what makes a public company promising or a failure. The fluff piece they put out yesterday worries me even more because two days ago they told me they haven't even received back information on their trial patches, so how are they going to market in "just a few weeks" with a product they haven't even received back market data on? You don't just enter a market and spend serious money without a plan on sales and how do you create a plan on sales if you dont have reviews on the product? They reference a 112B pain management market, but the bulk of that market is actual real pain killers, which I don't care how you want to spin it, they aren't competing in that market. By their claims, they are competing in the patch market, which is 1000th the size of what they are referencing, then eventually if they get into the pills, they will still only be competing in the more holistic side. I just feel they are being very misleading. Being misleading in OTC just leads to being more misleading.
Hopefully im wrong as hell.
what did you ask?
here comes that RS i warned you about like 5 months ago....
If i was CEO of a company, no i wouldn't. I personally will attend 4-5 conventions a year, its not news. It business as normal and something they should be doing several times a year. I've always felt that it just waters down PR's. Just put it on your website and move forward. Just my opinion.
lol nice fluff piece
there's still plenty of things they could PR about that it would be illegal for them to let anyone know in email about up front. I'm not trying to bash the stock, im just sharing the info presented to me and although none of it is doom and gloom for an investor at all, some of it just doesn't jive short term with some opinions here so I shared it because im a short term trader and some others are as well. Dr and Ngr and other true longs should care less about that, what's a few more months if you're looking out 5 years?
It is extremely odd to me though that the day the CEO releases what looks to be a very positive update on the company the stock begins an 80% tumble over the course of 4 weeks and in that time-frame the company confirms that their single lender has been "exercising restraint" in converting stock. It's just weird, but hopefully its just MMs doing what they need to do to artificially create a run like a lot of the folks have stated has happened here multiple times.
My interest is getting this thing above .01 so I can hop out.
All I did was restate what BIEI told me. If what they are telling me isn't true, then I can't help that. They have tested on mice, just not humanized mice, and they won't do that until they have humanized their antibody.
That's fine, i'm not a research assistant and I don't want my email on a forum. Just shoot them an email to satisfy your curiosity. I've received back 3 related to questions I've asked.
Redwood is not the result of this price drop, they have been very "restrained" according to them, they do not have feedback from their test pain patches yet, they are still working on supplier agreements for the pain patch if successful and do not have revenue projections yet, they believe their treatment will eventually receive patent (of course they would), and they believe their stock is undervalued.
"Regarding mouse trials, we have no trials in process at this time, as we are awaiting humanized versions of our antibody (about a 4 month process), after which testing on humanized mice will begin and last several months. We anticipate similar superior results against the leading currently available immunotherapy antibody in our future testing, as we observed in our past tests."
Feel free to say I wrote it now...
Hey Mr. Has no Idea, here's a novel idea. Why don't you email them yourself and ask them the same question, then keep your mouth shut when you get the exact same answer. I still own shares and have stated several times I have no plans on purchasing anymore, so what would be my purpose posting information that short-term shareholders find unpleasant? If you're an actual investor then what I posted makes no difference at all whatsoever.
Emailed and asked. The Q2 comment is my own, based on the timeframes from the response.
Yes.
From the horses mouth, there are no mice trials currently occurring. They have to humanize the antibody, which will be several more months, then they can move into mice trials. It will be Q2 before anything related to mice trials comes back
completely possible, but under what circumstances would they decide to not PR humanized mouse trials? that doesn't make any sense.
If i was forced to put a 100k bet on when. I would say Q4 of next year would be the soonest any human trials would occur.
The way it is worded in their most recent release, they are not in the middle of humanized mouse trials. There 0 reason for them not to announce that in a PR.
"The results of our laboratory testing on small animals so far have been very encouraging. As a result, we are currently in the process of humanizing our anti-cancer antibody, over the next several months, to facilitate testing towards eventual human clinical trials."
this week's "maybe next week" will be the last one. They can apply for an extension though.
I say what's on my mind. I learned a long time ago that ignoring the negative components and wishful thinking doesnt make pps rise:) The only thing i short is currency, so i never talk negative about a stock for that purpose. I found this as a short term play, then found it good for trades over a few day, then got screwed by a hurricane:)
I'm not negative about the pain patches. I think it's good that they are looking for a revenue stream. My career is in manufacturing and financials, so what im more negative about is acting like that product is somehow going to completely or even majorly fund the process of getting a drug to the market because I understand that that's not how things work. This patch could be the most revolutionary thing ever, but its still going take a reasonable amount of time to see net profits. If this company's ultimate goal is to put FDA approved drugs onto the market, $$$$$$$$ is needed and lots of it. As of today, i look at this thing as a whole and I would never invest long-term into it, I've just seen hundreds of these over the years. The road is long, and extremely curvy, uphill, with no railings, and lots of potholes:)
excuse me, 232k currently.
I recently dumped 485k around .095. still holding just 252k. Ive traded this probably 15 times since july/august. I made a good profit right there on that run up Oct 3-4 and sold, then went back in on a dip on the 5th and planned on selling in the low 2's, but hurricane matthew came through and ended up flooding my house and i didnt have power for 6 days and honestly I just wasnt thinking about trading at the time. By the time I checked around the 11th i was already in the red and falling since. made about 75% of the loss back trading other pennies since, but such is life.
The problem is there will be another...then another...
if their pain patch takes 100% of the US pain patch market starting next year and does so for 8 years straight, it could potentially fund 10% of average cancer drug trial cost....
It's a freaking pain patch....it will be competing with 10 other companies with decades of established brand names. You're dreaming.
if their pain patch takes 100% of the US pain patch market starting next year and does so for 8 years straight, it could potentially fund 10% of average cancer drug trial cost....
It's a freaking pain patch....it will be competing with 10 other companies with decades of established brand names. You're dreaming.
they don't understand that concept and believe a pain patch is going to somehow fund trials of their wonder drug that they don't even have a patent on.....
There's 3 or 4 people here who've said we've reached bottom and it's time to reload every week for the past 4 weeks. It's been in freefall and still is on a daily. Watch the action today and if it seems positive and continues that trend, i'd look to buy in tomorrow late or Monday. my 2 cents.
Statistically speaking, they have a close to 0 shot of uplisting once getting moved to the pink sheets. They should care.
If there's not revolutionary news next week picking this back up above .01, i'd be wary of a emergency r/s before the 20th of Nov to avoid delist.
Why? you can buy it cheaper tomorrow
no offense bud, but there's a few months of evidence here to say your sources suck.
They've blown past every estimate i've seen on this forum for $ needed to raise, so no one here has a clue. While your comment that fundamentals don't mean anything with dilution is correct, they really don't mean anything on OTC 99% of the time. When fundamentals start to make sense the company is usually off of OTC because they actually have fundamentals. There are no fundamentals here and literally every piece of positive news is just PR's from the company itself, so its hard to take that all for face value.
You say this is the only way Hartmann can raise cash, where is the rest of the needed cash going to come from? I keep hearing JV, but what company is going to partner with a bio that doesn't have a patent on their wonder drug? Until a patent there won't be a legitimate JV, and until there's a JV they can't possibly even begin to pay for the paperwork to move into real trials. The light shown on the patent issues recently is a lot more important than I see anyone comment on. I don't wish anyone losses, I only wish everyone makes cash hand over fist and I hope that tomorrow Hartmann announces they are bought by Pfizer or signed an agreement with Glaxo, but I really don't think that's the case.
I think they are in a more troublesome spot then you seem to let on. There's dilution, then there's a pump with a 70% value loss in 25 days.
Patents, or attempts to get patents, and even looking into trials. 100k/mo is pennies looking forward.
"...we have reduced the number of lenders from as many as five at once in the past, to just one. We believe this will reduce the selling pressure into the market and may be a catalyst to allowing our stock to achieve its true potential" he made that same comment what...4-5 months ago?
it'll be next week
another solid day at biei
true, but most of those companies aren't looking at $1B-$5B of expenditures over the next decade to get a cancer drug to market and aren't trying to patent a cancer treatment. It throws a wrench in whole thing. If the pain patch company was its own publicly traded company, I would be putting money into it long-term just as a gamble based on their perceived effectiveness of the product. They have manufactured some test patches, but they don't have manufacturing agreements yet because they don't know the demand of the product, so no one has any idea of potential net profit and how that could potentially offset the tremendous costs coming their way. It's all just guesses based off the CEO's comments or brief sentences...who is a smidgen biased:)
I wouldn't expect that to give you anything other than a spike though. Would need at least a quarter of sales data to decide what the patch sales are/could be worth. I think just some responses back on the effectiveness of the product from multiple sources would do a lot more than even discussing sales, because sales forecasts don't really mean much until you have proven sales history. They are going to have to completely dominate the pain patch market and become the #1 seller in a short timeframe for it to even really put in a dent in the $ requirements for them to move their cancer research forward.
"I'm selling the greatest ice cream ever made several months from now, believe it's the best because I said it's the best, invest" Kind of the model here on that front so far until we get some reviews back.